These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 309921)

  • 1. The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity.
    Berendt MJ; North RJ; Kirstein DP
    J Exp Med; 1978 Dec; 148(6):1550-9. PubMed ID: 309921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity.
    Berendt MJ; North RJ; Kirstein DP
    J Exp Med; 1978 Dec; 148(6):1560-9. PubMed ID: 309922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma.
    North RJ; Havell EA
    J Exp Med; 1988 Mar; 167(3):1086-99. PubMed ID: 3258350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic significance of concomitant antitumor immunity. II. Passive transfer of concomitant immunity with Ly-1+2- T cells primes established tumors in T cell-deficient recipients for endotoxin-induced regression.
    North RJ
    Cancer Immunol Immunother; 1984; 18(2):75-9. PubMed ID: 6391656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtherapeutic numbers of tumour-sensitized, L3T4+, Ly 1+2- T cells are needed for endotoxin to cause regression of an established immunogenic tumour.
    Digiacomo A; North RJ
    Immunology; 1987 Mar; 60(3):367-73. PubMed ID: 2952585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin.
    Balza E; Mortara L; Sassi F; Monteghirfo S; Carnemolla B; Castellani P; Neri D; Accolla RS; Zardi L; Borsi L
    Clin Cancer Res; 2006 Apr; 12(8):2575-82. PubMed ID: 16638868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumors.
    Awwad M; North RJ
    Cancer Res; 1990 Apr; 50(8):2228-33. PubMed ID: 2317810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells.
    North RJ
    Cancer Immunol Immunother; 1984; 16(3):175-81. PubMed ID: 6231095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective radiation resistance of immunologically induced T cells as the basis for irradiation-induced T-cell-mediated regression of immunogenic tumor.
    Dunn PL; North RJ
    J Leukoc Biol; 1991 Apr; 49(4):388-96. PubMed ID: 1900523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublethal, whole-body ionizing irradiation can be tumor promotive or tumor destructive depending on the stage of development of underlying antitumor immunity.
    Awwad M; North RJ
    Cancer Immunol Immunother; 1988; 26(1):55-60. PubMed ID: 2964269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice.
    Shu S; Chou T; Rosenberg SA
    Cancer Res; 1987 Mar; 47(5):1354-60. PubMed ID: 3102046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients.
    North RJ
    Cancer Immunol Immunother; 1984; 18(2):69-74. PubMed ID: 6334549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activity.
    Shimizu Y; Hasumi K; Masubuchi K; Okudaira Y
    Eur J Immunol; 1988 Nov; 18(11):1773-8. PubMed ID: 2974424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.
    North RJ
    J Exp Med; 1982 Apr; 155(4):1063-74. PubMed ID: 6460831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity.
    North RJ; Neubauer RH; Huang JJ; Newton RC; Loveless SE
    J Exp Med; 1988 Dec; 168(6):2031-43. PubMed ID: 3143799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-mediated inhibition of endotoxin-induced intratumor tumor necrosis factor production and tumor hemorrhagic necrosis and regression.
    North RJ; Havell EA
    J Exp Med; 1989 Sep; 170(3):703-10. PubMed ID: 2788707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
    Li J; Hu P; Khawli LA; Epstein AL
    Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive immunotherapy of newly induced murine sarcomas.
    Shu SY; Rosenberg SA
    Cancer Res; 1985 Apr; 45(4):1657-62. PubMed ID: 3872168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.